Primary gastrointestinal stromal tumor (GIST) is a type of tumor often found in the stomach or small intestine.
Preliminary data of a large, randomized, placebo-controlled clinical trial which tested imatinib mesylate (Gleevec ®) in patients with primary gastrointestinal stromal tumor (GIST) following complete removal of their tumor were found to be significantly less likely to have a recurrence of their cancer compared to the placebo group.
According to Elias A. Zerhouni, M.D., NIH Director:
“The standard treatment for primary GIST is complete surgical removal of the tumor without additional therapy. It is excellent news that addition of this well-tolerated cancer pill to the …read more